adenosine has been researched along with Lung Neoplasms in 125 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (6.40) | 18.7374 |
| 1990's | 3 (2.40) | 18.2507 |
| 2000's | 5 (4.00) | 29.6817 |
| 2010's | 25 (20.00) | 24.3611 |
| 2020's | 84 (67.20) | 2.80 |
| Authors | Studies |
|---|---|
| Li, Q; Wang, C; Xiong, Y; Yang, X; Zhang, D; Zhang, R | 1 |
| Guo, M; Li, Z; Ming, L; Qin, Z; Wan, J; Wang, Y; Yang, Z; Zhao, Z; Zheng, J | 1 |
| Gao, S; He, J; Luo, Y; Sun, N; Tan, F; Wang, L; Wu, P; Xue, L; Xue, Q; Yang, Z; Zeng, H; Zeng, Q; Zhang, C; Zhang, G; Zhang, Z; Zheng, B | 1 |
| Chen, YM; Chien, CS; Chien, Y; Chiou, SH; Hsiao, YJ; Hsu, PK; Liang, Y; Lin, TW; Lin, TY; Luo, YH; Teng, PC; Teng, YC; Wang, ML; Yang, YP; Yarmishyn, AA | 1 |
| Bai, Z; Wu, X | 1 |
| Cai, J; Guo, Y; Huang, C; Huang, Y; Li, R; Li, Y; Liu, A; Liu, B; Lu, W; Ren, D; Ren, L; Tong, J; Wu, M; Zhang, C; Zhang, X; Zheng, Y | 1 |
| He, J; Luo, Y; Sun, N; Wang, L; Wu, P; Xue, Q; Yang, Z; Zeng, Q; Zhang, C; Zhang, G; Zhang, Y; Zhang, Z | 1 |
| Fu, G; Jiang, M; Qu, J; Wang, L; Wei, Z; Zhang, X | 1 |
| Bao, F; Chu, X; Feng, L; Sun, Z; Wang, W | 1 |
| Dong, Z; Feng, W; Gao, M; Han, J; Huang, H; Huang, J; Kloeber, JA; Liu, S; Lou, Z; Qi, Z; Xu, M; Xu, Z | 1 |
| Chen, B; Hu, Z; Zhang, Y; Zhu, L | 1 |
| Ding, H; Gao, C; Kong, N; Li, J; Sun, Z; Tang, T; Wu, L; Xu, M; Zhang, F | 1 |
| Patel, A; Patel, L; Patel, M; Patel, S; Shah, S; Shah, U; Solanki, N | 1 |
| Guo, J; Li, M; Xu, Y | 1 |
| Huang, T; Ye, W | 1 |
| Colombo, MP; Ferrara, R; Garassino, MC; Milani, M; Sangaletti, S | 1 |
| Heymach, J; Le, X | 1 |
| Cui, Z; Guo, B; Jia, E; Ren, N; Xue, J; Zhang, B | 1 |
| Antonia, S; Aregay, M; Barlow, ML; Beg, AA; Boyle, TA; Castro, J; Chen, DT; Chen, Z; Chiappori, AA; Creelan, B; Gray, JE; Haura, EB; Hurtado, FK; Manenti, L; Morgan, L; Morris, E; Tanvetyanon, T; Thapa, R | 1 |
| Dong, C; Fu, Z; Li, D; Song, Y | 1 |
| Belisario, DC; Bertolini, G; Bracci, C; Compagno, M; Ferracini, R; Genova, T; Horenstein, A; Malavasi, F; Mussano, F; Roato, I; Vitale, M | 1 |
| Cui, J; Du, X; Ke, J; Ma, B; Yang, X; Yu, L | 1 |
| Bai, L; Chen, Q; Hu, CP; Jiang, J; Li, YY; Wan, RJ; Zhang, Y; Zhao, BR | 1 |
| Kim, EY; Kim, GT; Kim, JW; Lee, H; Lee, SH; Shin, SH; Sohn, KY | 1 |
| Huang, Y; Ma, M; Wang, B; Wang, W; Yang, Y; Ye, L; Zhao, G | 1 |
| Bernal-Crespo, V; Cao, J; Chambers, AM; Elzey, BD; Jalal, S; Lanman, N; Lupo, KB; Matosevic, S; Pine, SR; Torregrosa-Allen, S; Utturkar, S; Wang, J | 1 |
| Chen, Y; Liao, X; Ling, Q; Liu, C; Wu, S | 1 |
| Bai, Y; Liu, J; Liu, X; Shi, Y; Wang, M; Xu, Y; Zhang, D | 1 |
| Amann, JM; Carbone, DP; Dikov, MM; Guan, S; Suman, S; Wang, J; Wu, R | 1 |
| Cai, F; Fu, Y; Gai, Y; Ge, X; Qin, X; Shang, Y; Xiao, H; Xu, J; Zhou, C | 1 |
| Chen, H; Hu, B; Lyu, Y; Qian, D; Shao, G; Yan, Q; Zhu, L | 1 |
| Al-Hroub, H; Idris, R; Lopez, V; Mirza, S; Müller, CE; Pelletier, J; Schäkel, L; Sévigny, J; Tolosa, E; Winzer, R | 1 |
| Liu, H; Ma, J; Mao, Y; Zhang, L | 1 |
| Bauer, TM; Bendell, JC; Chen, H; Choe, JH; Das, M; Drake, CG; Falchook, GS; George, DJ; Hattersley, MM; Karlix, JL; Kumar, R; Lim, EA; Moorthy, G; Patel, MR; Pilling, EA; Pouliot, GP; Russell, DL; Sachsenmeier, KF; Sidders, BS; Ulahannan, S | 1 |
| Ge, H; Jin, L; Wang, N; Wang, X; Wang, Y; Wu, S; Xu, Y; Zhao, J; Zhou, F | 1 |
| Bai, G; Bie, F; Gao, S; Liu, L; Peng, Y; Song, P; Zang, R; Zhang, M; Zhao, J; Zhou, B | 1 |
| Guo, MY; He, JQ; Qiu, FS; Yu, CH; Zhong, YS | 1 |
| Abudurufu, M; Cai, HY; Chen, TF; Ke, ZF; Lei, YY; Luo, HH; Shan, SC; Yang, HS; Zhu, Y; Zou, JY | 1 |
| Feng, M; Li, Q; Liao, W; Qian, Z; Wen, F; Wu, Q; Yang, Y | 1 |
| Li, L; Xu, L; Yan, C; Zhou, L | 1 |
| Hui, H; Jiang, B; Li, D; Li, H; Lin, Y; Luo, M; Miao, H; Zhang, Y | 1 |
| Asadi, J; Asgharkhah, E; Jafari, SM; Saghaeian Jazi, M | 1 |
| Chen, H; Cheng, J; Du, J; Fu, J; Fu, S; Guo, K; He, J; He, T; Li, D; Li, T; Liu, S; Liu, X; Liu, Z; Qian, J; Song, B; Tan, Q; Zhang, L; Zhou, B | 1 |
| Cai, X; Zhang, X | 1 |
| Chen, KJ; Gu, DL; Ho, CM; Hsiao, CH; Hsu, YH; Huang, JH; Jen, HW; Jou, YS; Kung, YC; Lang, YD; Lee, HY; Lee, SS; Shen, R; Shih, JH; Wu, CY | 1 |
| Guo, Z; Wang, X; Yan, F | 1 |
| Guo, Z; Huang, Y; Lai, S; Li, T; Lin, C; Wang, Y; Weng, S; Zhang, X | 1 |
| Akbay, EA; Kowash, RR | 1 |
| Amann, J; Antonucci, A; Arasada, RR; Bobko, AA; Carbone, DP; Castro, J; Dikov, MM; Driesschaert, B; Evans, JV; Feoktistov, I; Goruganthu, MUL; Guan, S; Hoyd, R; Ilgisonis, I; Ivanova, AV; Kanagasabai, T; Khramtsov, VV; Kikuchi, T; Novitskiy, SV; Owen, DH; Pallerla, A; Park, KP; Piao, L; Ryzhov, SV; Samouilov, A; Shanker, A; Spakowicz, DJ; Suman, S; Tchekneva, EE; Uzhachenko, RV; Wei, L; Wu, R; Zweier, JL | 1 |
| Cai, Y; Guo, MM; Li, Y; Liu, MY; Ming, DJ; Wang, DQ; Wang, SY; Xi, S; Yuan, S; Zhang, JH; Zhang, YJ | 1 |
| Chen, G; Ren, D; Wang, H; Wang, Y; Yang, S; Zhang, J | 1 |
| Fu, N; Teng, Y; Xi, Y; Zhao, X | 1 |
| Brunetti, L; Chung, Y; Clark, J; Cortellini, A; Gramenitskaya, D; Hafiz, M; Iivanainen, S; Jiwani, RA; Jonnalagadda, S; Koivunen, JP; Lee, JS; Lee, SH; Macherla, S; Marie, MA; McCallen, JD; Mi, E; Muzaffar, M; Naqash, AR; Pinato, DJ; Polsani, S; Ruppin, E; Stroud, CRG; Walker, PR; Wang, K; Yang, LV | 1 |
| Jiang, W; Liu, H; Ma, X; Meng, Q; Wang, S; Xu, C; Zhou, S; Zhou, X | 1 |
| Chen, Y; Fu, AS; Ge, YL; Li, WQ; Shao, DF; Wang, HY; Wang, MH; Zhang, C; Zhang, Q; Zhu, XY | 1 |
| Chao, Y; Ji, W; Shang, J | 1 |
| Chen, L; Chen, Z; Deng, Q; Dinglin, X; Hou, X; Huang, H; Li, D; Ling, Y; Lv, Z; Ma, S; Peng, Y; Wang, H; Wu, Y | 1 |
| Chen, J; Chen, Y; Lin, L; Xu, F; Zhang, H | 1 |
| Chen, P; Ma, L; Qian, Q; Zhao, X; Zhu, Z | 1 |
| Chen, F; Chen, Z; Li, J; Lin, X; Lv, Z; Peng, Y; Wang, H | 1 |
| Cao, Y; Chen, L; Chen, X; Li, L; Zhou, C | 1 |
| Hu, Q; Li, J; Liu, L; Liu, X; Sun, R; Zhang, Y | 1 |
| Chen, JZ; Chen, WW; Hang, Y; Qi, JW; Wang, HH; Wang, J; Wu, JX; Zhou, XX | 1 |
| Chen, Q; Chen, Y; Ding, P; Gao, K; He, Q; Ling, L; Song, Y; Wang, L; Wang, Y; Wu, W; Xiong, J; Yan, J; Yang, L; Yang, W; Zhai, R; Zou, P | 1 |
| Aasen, T; Abdul Moin, NI; Abdul Wafi, S; Aboukameel, A; Abu-Bakar, N; Acharya, A; Ackermans, L; Adaramoye, O; Adarsh, KV; Adeosun, WA; Ahmad, NH; Ahmadi, F; Akanni, O; Akbar, M; Akbulak, RO; Akev, N; Akkaya, Ö; Al-Rashed, S; AlAbbad, S; Alabi, O; Alappat, BJ; Alcalá, S; Alcoutlabi, M; Aleppo, G; Alexander Ross, JB; Alexander, JH; Alexander, R; Alias, A; Alimba, C; Alken, FA; Allan, R; Alpers, M; Alsbou, EM; Amarasiri, SS; An, T; Anastasiadis, F; Anastassiadou, M; Anderson, KC; Andronikos, P; Anheyer, D; Annapurna, K; Anorlu, RI; Anten, MM; Anthopoulos, TD; Araujo-Castillo, RV; Aravamudhan, S; Arawwawala, LDAM; Arulsamy, N; Arunamata, A; Asghar, A; Asiri, AM; Aslanidou, T; Astrakhantseva, IV; Astutik, E; Attanayake, AP; Atwater, BD; Audureau, E; Augusto, S; Bakare, A; Banach, M; Bandelier, P; Banerjee, S; Barral, M; Bascuñán, J; Bates, FS; Bauer, NJC; Bayrak, BB; Beck, RW; Beckervordersantforth, J; Beeri, R; Begum, R; Beldi-Ferchiou, A; Bellingham, G; Ben-Tal, N; Bendib, I; Bergenstal, RM; Berger, MF; Bernasconi, G; Berry, S; Beuvon, F; Bi, WJ; Bi, Z; Bianconi, V; Bibi, I; Blank, BR; Bliemeister, E; Bobkowski, W; Bode, AM; Booth, CM; Bose, U; Boyd, K; Brancato, A; Brenmoehl, J; Brogi, E; Bronzo, P; Brooks, T; Brown, D; Brown, DN; Bruce, D; Buan, MEM; Bueno-Hernández, F; Bugielski, B; Bulavaitė, A; Buscagan, TM; Buxton, R; Caffaro, MM; Cai, Q; Cai, X; Cai, Y; Calhoun, P; Callander, N; Cambier, S; Camparo, P; Canales-Vargas, EJ; Canham, K; Cantu, J; Cao, J; Cao, JW; Cao, P; Cao, T; Cao, X; Caravella, BA; Carcadea, E; Carè, J; Carmichael, P; Carrasco Cabrera, L; Carteaux, G; Carvalho, PDS; Casarez, E; Cazorla, M; Celestrin, CP; Chakraborty, NK; Chan, B; Chandarlapaty, S; Chandgude, AL; Chang, CC; Chang, JH; Chang, X; Chang, Y; Chankhanittha, T; Chantanis, S; Chapovetsky, A; Chavan, S; Chen, B; Chen, D; Chen, F; Chen, G; Chen, H; Chen, J; Chen, K; Chen, KJ; Chen, KP; Chen, L; Chen, MA; Chen, Q; Chen, S; Chen, W; Chen, WF; Chen, X; Chen, Y; Cheng, D; Cheng, J; Cheng, Q; Cheon, GJ; Chiu, SC; Cho, CH; Cho, J; Choi, H; Choi, JS; Choi, YH; Christie, P; Chu, CH; Chu, Y; Chung, DH; Chung, F; Cline, JP; Cohen, A; Cohen, AD; Cohen, NJ; Comen, E; Compter, I; Cong, J; Cong, Z; Cooper, A; Cornud, F; Costa, C; Costa, S; Covey, A; Cowan, AM; Cramer, H; Cruz-Rivera, C; Cui, J; Cui, M; Cui, Y; Cui, YH; Culquichicón, C; Cushman, T; D'Auria, SJ; da Silva, J; Dalgediene, I; Danenberg, HD; Das, S; Dasgupta, K; Daubit, IM; de Oliveira, PD; de Prost, N; De Ruysscher, D; Dearman, K; Decato, D; Delfau-Larue, MH; Deng, L; Dhakate, SR; Dharuman, V; Di Costanzo, N; Dickler, MN; Dinehart, EE; Ding, D; Dinh, TK; Divya, KP; Djifack Tadongfack, T; Do, T; Domínguez-Roldan, R; Domínguez-Zambrano, E; Dömling, A; Donato, MD; Dong, JH; Dong, W; Dong, X; Dong, XR; Dong, Y; Dong, Z; Downs, M; Drutskaya, MS; Du, B; Du, F; Du, H; Du, L; Du, X; Duan, Z; Duangthip, D; Dunstand-Guzmán, E; Duong, F; Eckert, DJ; Edelhäuser, BAH; Eekers, DBP; Efendi, F; Efraimidis, P; Ehrenberg, H; Ehsanbakhsh, Z; Eickholt, C; Eksterowicz, J; El Mobadder, M; El-Araby, IE; El-Magd, MA; El-Tarabany, MS; Elgorban, AM; Engelmann, D; English, KL; Esfandiari, H; Eslami, B; Espinosa-Cuevas, A; Eswara, S; Faber, E; Fan, XH; Fan, Y; Fang, J; Fang, Z; Fantin, VR; Fei, P; Feng, G; Feng, H; Feng, J; Feng, X; Feng, XJ; Fennell, TR; Fernández-Moreira, V; Ferraz, ABF; Ferreras, KN; Flores, K; Flores-Pérez, I; Flox, C; Fluharty, FL; Fokouong Tchoffo, E; Folefack, GO; Foroutan, T; Fort, D; Fourati, S; Fousas, S; Frapard, T; Freguia, S; Friedman, DJ; Friedman, LS; Fu, D; Fu, Q; Fu, Y; Fujinami, S; Furihata, K; Gal, RL; Gan, H; Gao, C; Gao, F; Gao, R; Gao, SS; Gao, W; Gao, XC; Gao, Y; Gao, Z; Garozi, L; Ge, J; Georgiopoulos, A; Gerakiou, K; Ghazimirsaeed, SM; Ghazimirsaeed, ST; Gimeno, MC; Gjestad, R; Glurich, I; Goetchius, E; Goland, S; Goldstein, S; Gonçalves, CM; Gonçalves, H; Gong, Q; Gonzalez, D; Goplen, FK; Gorshkova, EN; Gotsman, I; Govindasamy, V; Granger, CB; Greco, L; Grigoriadou-Skouta, E; Grigoropoulos, P; Grivicich, I; Gromov, NV; Gruber, S; Grytczuk, M; Grzech-Leśniak, K; Gu, L; Gu, S; Gu, Z; Guadagnini, D; Guan, H; Guilliams, M; Guo, J; Guo, L; Gupta, A; Gupta, SK; Gurzu, S; Gutleb, AC; Haban, A; Hablitz, JJ; Hadisuyatmana, S; Hahn, S; Haiges, R; Hallal-Calleros, C; Hamed, M; Hammad, N; Hammer, N; Han, C; Hao, Y; Harnett, J; Has, EMM; Hassanpour, K; Hatzopoulos, D; Hawaldar, R; He, X; He, Y; He, YY; He, Z; Heberman, D; Heckl, D; Hegde, H; Henson, MA; Hernández-Velázquez, VM; Herrera, E; Hijazi, Z; Hirayama, K; Hirth, JM; Hoeben, A; Hohnloser, SH; Hong, M; Hood, K; Hoplock, LB; Hopman, WM; Horlbogen, LM; Hossein Rashidi, B; Hou, G; Hou, H; Hou, J; Hou, Y; Hu, J; Hu, W; Hu, X; Hua, W; Huang, G; Huang, H; Huang, J; Huang, T; Huang, W; Huang, Y; Huang, YD; Huang, Z; Hudis, CA; Hue, S; Huo, J; Hussain, M; Hvas, AM; Ichii, T; Ide Zeuna, J; Ilyas, S; Inoue, T; Iranzo, A; Irfan, M; Iwasa, Y; Iwashita, Y; Izgorodina, EI; J R, A; Jaber, WA; Jaborek, JR; Jacobus, SJ; Jadeja, SD; Jafarabadi, M; Jalan, D; Jamil, MI; Jarrah, S; Jarvis, D; Jayatilaka, KAPW; Jemal-Turki, A; Jeon, YK; Jeong, N; Jeong, SH; Jeong, SY; Jermy, M; Jhaveri, K; Ji, H; Ji, K; Ji, RY; Jiang, F; Jiang, J; Jiang, X; Jiang, Y; Jiao, Q; Jilani, K; Jiménez-Guerrero, P; Jin, L; Jo, YH; Johnson, JG; Johnson, ML; Jones, WS; Jose, S; Jularic, M; Jung, I; Jung, YJ; Jungen, C; Junttila, MR; Kache, S; Kahanovitch, U; Kalantzi, KI; Kallio, T; Kamnoedboon, P; Kang, CH; Kang, H; Kang, J; Kang, KW; Kapoor, P; Karmakar, D; Kartalis, A; Kauranen, P; Kazocina, A; Keikha, F; Keltai, M; Kershaw, SV; Kettani, M; Khalvati, S; Khandhar, S; Khosla, N; Kiely, CJ; Kim, CC; Kim, H; Kim, MJ; Kim, Y; Kim, YH; Kim, YT; Kimoto, E; Kiyu, A; Klatt, N; Kobayashi, M; Koh, J; Köhler, R; Kondadasula, SV; Kong, H; Kong, W; Kong, X; Kotidis, A; Kotwal, A; Kouvari, M; Kozhinov, AN; Kruger, D; Kuang, S; Kuang, Y; Kubota, M; Kuklik, P; Kumar, P; Kumar, SK; Kuo, YF; Kurup, SP; Kusuhara, H; Kuswanto, H; Lacouture, ME; Lambin, P; Lang, CC; Langroudi, FH; Lanman, RB; Larsen, OH; Laskin, J; Le, VH; Leach, M; Lee, BG; Lee, DF; Lee, DS; Lee, HJ; Lee, SB; Lee, YA; Lei, Y; Lekashvili, O; Lelj, F; Lemin, AS; Lemoine, J; Leuschner, R; Li, B; Li, BT; Li, C; Li, D; Li, F; Li, G; Li, H; Li, HW; Li, J; Li, M; Li, P; Li, Q; Li, S; Li, W; Li, X; Li, XY; Li, Y; Li, Z; Lian, Y; Liang, C; Liao, J; Liao, W; Liao, Y; Lin, D; Lin, W; Lin, YL; Lindbäck, J; Lindsay, AP; Ling, J; Linser, PJ; Liu, C; Liu, H; Liu, JJ; Liu, L; Liu, Q; Liu, SF; Liu, X; Liu, Y; Liu, Z; Liu, ZM; Lo Sterzo, C; Lo, ECM; Lobchuk, MM; Lodge, TP; Logotheti, S; Lonial, S; Lopes, G; Lopes, RD; Lopez, J; Lopez, SA; López-Santos, AL; López-Sendón, JL; Loring, Z; Louis, C; Lovita, AND; Lu, DZ; Lu, H; Lu, J; Lu, K; Lu, TT; Lu, Y; Luengo, A; Lum, LG; Luna, JM; Luo, L; Luo, R; Luo, T; Luo, X; Luo, Z; Lv, B; Lymperopoulos, N; Lyras, A; Lyu, Y; M Kannan, A; Ma, H; Ma, M; Ma, Q; Ma, S; Ma, WY; Ma, Y; Maalouf, E; Machado, FA; Maeda, K; Magrans, JO; Maharani, A; Maia, G; Mainwaring, RD; Maji, TK; Majumdar, K; Mannarino, MR; Mansuri, MS; Marinescu, SC; Markatos, G; Marquardt, S; Marraiki, N; Martens, C; Martínez, TJ; Marumo, K; Maruyama, H; Marwani, HM; Marzo, I; Masrati, G; Matamba, P; Mathialagan, S; Matys, J; Mayatra, JM; Mboua, PC; McArthur, T; McCrimmon, RJ; McIntosh, S; McSpadden, S; Medina-Campos, ON; Medvedovsky, AT; Mei, Z; Mekontso-Dessap, A; Menezes, AMB; Meng, J; Meng, P; Meng, Y; Menter, A; Mets, MB; Mets-Halgrimson, R; Metzger, T; Metzler-Nolte, N; Meyer, C; Mi, Y; Michailoviene, V; Mikrogeorgiou, A; Militz, H; Miller Iii, TF; Minarowska, A; Mir, S; Miron, I; Miyake, T; Moayer, F; Modi, S; Moeller, SJ; Mohamad, MN; Mohammed, EHM; Mokhonov, VV; Mondal, A; Moore, J; Moravcova, M; Mordi, IR; Mordi, NA; Mortensen, NP; Moscariello, C; Moser, J; Moynahan, ME; Mu, J; Mu, W; Mudduwa, LKB; Mukherjee, S; Mukhtar, A; Mulkey, DK; Murr, N; Mushtaq, Z; Muthuswamy, N; Mutlu, O; Muto, C; Myroforou, I; Na, KJ; Nabi, M; Nagornov, KO; Nagy, RJ; Naik, A; Nakajima, K; Nam, KT; Nam, YW; Namburath, M; Nammour, S; Namour, A; Namour, M; Nanan, S; Natsume, H; Nave, S; Naveed, A; Nazir, H; Ndubaku, C; Nedospasov, SA; Neradilek, MB; Newcomb, C; Nguépy Keubo, FR; Nguyen, M; Ning, J; Ning, Q; Noguchi, S; Nordahl, SHG; Nordfalk, KF; Norton, L; Noupoue, EM; Nouri, SS; Nowak, JK; Núñez, K; Oakes, K; Odegaard, JI; Ogorodnikova, OL; Ogunsuyi, O; Oh, HK; Oh, HR; Oh, KH; Ohgi, K; Okunade, KS; Oliveira, AG; Olorunfemi, G; Olsen, ML; Olson, BA; Omari, KW; Ondruschka, B; Orfali, R; Orkopoulos, A; Orlowski, RZ; Oser, SM; Oser, TK; Özcan, M; Padilla, V; Paeng, JC; Pajuelo-Lozano, N; Pal, SK; Palmieri, S; Palomeque, E; Pan, W; Panagiotakos, DB; Pandey, M; Pang, D; Pang, Q; Pangarah, CA; Panny, A; Paparella, A; Papirio, S; Papouskova, K; Parang, K; Park, HJ; Park, IK; Park, S; Parker, TL; Parkhomenko, A; Parmon, VN; Parsons, B; Parsons, J; Patel, PR; Patil, S; Patsourakos, NG; Patterson, KC; Pavlidis, P; Pedernera, M; Pedersen, R; Pedraza-Chaverri, J; Pellegrini, M; Peña-Chora, G; Pereira, EDM; Pereira, MADS; Peretz, A; Perez-Padilla, R; Perlman, GY; Perona, R; Petras, C; Phuntsho, S; Picada, JN; Pinder, TA; Piper, LFJ; Pirozzi, F; Pirro, M; Pleckaityte, M; Ploutz-Snyder, LL; Ploutz-Snyder, R; Pogorzelski, A; Poles, L; Postma, AA; Prager, A; Prakash, J; Punn, R; Pützer, BM; Qi, J; Qi, MC; Qi, Y; Qian, J; Qian, Y; Qiang, L; Qiu, J; Qu, Y; Rabiu, KA; Rahighi, S; Rahman, MM; Rahmani, B; Rajkumar, SV; Ramanathan, R; Raras, TYM; Rashi, Y; Rasool, G; Rathore, MG; Ratnawati, R; Ratola, N; Raucci, U; Ray, SK; Razavi, P; Razazi, K; Razek, S; Razi, SS; Reback, M; Reddy, K; Rees, DC; Reginatto, FH; Reich, H; Reis-Filho, JS; Ren, X; Ren, Y; Renner, G; Rey, G; Reymen, B; Riaz, M; Ricci, A; Richardson, PG; Richter, C; Riga, M; Ritchie, C; Rivoal, S; Roberts, W; Robson, ME; Rocha, GZ; Rodrigues, AD; Rogach, AL; Rojas, A; Rosenberg, A; Rosenberg, E; Rosenheck, RA; Roslan, K; Rothenberger, C; Rouschop, KMA; Rubagumya, F; Ryan, CM; Ryder, JW; Saad, MJA; Sacan, O; Sacchi, A; Sahebkar, A; Saini, A; Sainz, B; Sajo, EA; Sakizadeh, J; Saleh, AA; Salgado Júnior, IB; Salvi, R; Samoylova, YV; Samuni, A; Sanchez, DM; Sanchez-Perez, I; Santos, M; Sarapulova, A; Sardot, T; Saud, N; Sauerbier, P; Scaltriti, M; Schaeffer, B; Schalk, DL; Scherschel, K; Schijven, MP; Schreuder, HWR; Schuhmacher, M; Schultz-Lebahn, A; Schwarzl, J; Scott, JM; Sebayang, SK; Seeger, ZL; Segabinazi Peserico, C; Selenica, P; Serio, A; Seruga, B; Shah, A; Shah, C; Shah, PD; Shahrokh Tehraninezhad, E; Shan, A; Shao, Z; Sharma, AMR; Sharma, RK; Shen, J; Shen, R; Shi, X; Shi, Y; Shi, ZE; Shih, YC; Shimohata, H; Shimpi, N; Shin, SH; Shon, HK; Shuvy, M; Siddique, AB; Siegbahn, A; Sikandar, M; Silvani, Y; Singh, A; Singh, AK; Singh, D; Singh, JS; Singh, KP; Singh, M; Situ, B; Skipper, MT; Skouloudi, M; Sloane, BF; Smyrnioudis, N; Snyder, MA; Söhnchen, C; Solis Condor, R; Solit, DB; Someya, S; Song, H; Song, J; Song, W; Song, Y; Sorokina, KN; Soshi, S; Soyer, P; Spitschak, A; Sreekrishnan, TR; Srinivasan, M; Staruschenko, A; Steel, A; Stefan-van Staden, RI; Stein, AM; Strayer, H; Struthers, AD; Su, H; Su, Q; Su, X; Sudore, RL; Sugimura, H; Sugiyama, Y; Sujuti, H; Sumner, SJ; Sun, B; Sun, D; Sun, H; Sun, J; Sun, JY; Sun, X; Sun, Y; Sun, Z; Sung, YC; Surenaud, M; Sutimantanapi, D; Suwandaratne, NS; Swaroop, S; Sychrova, H; Syed, A; Szczepanik, M; Szederjesi, J; Szodorai, R; Tacy, TA; Tadelle, RM; Takayasu, M; Tammeveski, K; Tan, H; Tan, M; Tang, HX; Tang, S; Tang, X; Tanokura, M; Tao, F; Tao, H; Tarafdari, A; Tarín-Carrasco, P; Tasson Tatang, C; Teixeira, JP; Thakur, A; Theobald, A; Thevenot, P; Thomaidis, K; Tian, J; Tillib, SV; Toma, C; Tomita, M; Tonchev, I; Tong, F; Toy, W; Trypuć, M; Tselepis, AD; Tsetseris, L; Tsikouri, GE; Tsikouris, EI; Tsoplifack, CB; Tsoumani, ME; Tsujimoto, R; Tsybin, YO; Tu, J; Tu, TM; Turco, M; Turkyilmaz, IB; Uddin, MJ; Ung, J; Unsihuay, D; Utsunomiya, T; Vagenende, B; Vaishnav, J; Valdes, C; Validad, MH; Valle, J; van Ginkel, MPH; van Grevenstein, WMU; Vanderpuye, V; Vasan, N; Vasilenko, EA; Vasques, GJ; Vavoulis, P; Verani, A; Veziroglu, E; Viegas, A; Vitali, MG; Vitsas, G; Voccio, JP; Vogiatzidis, C; Volow, A; Volpin, F; Vourvahis, M; Wagner, LI; Walkowiak, J; Wallace, R; Wallentin, L; Wan, D; Wan, L; Wan, T; Wang, C; Wang, F; Wang, FN; Wang, H; Wang, J; Wang, L; Wang, Q; Wang, S; Wang, T; Wang, W; Wang, X; Wang, XW; Wang, Y; Wang, YS; Wang, Z; Ward, J; Ward, L; Waseem, R; Watson, DF; Weber, P; Wehrmeister, FC; Wei, CH; Wei, H; Wei, L; Wei, Q; Wei, Y; Weinstock, RS; Weiss, M; Welborn, M; Wen, L; Wen, LM; Wen, Q; Wen, Z; Wesseling, P; Westerbergh, J; White, K; Wick, MP; Willems, S; Wiyasa, IWA; Wójciak, R; Wolkenhauer, O; Won, HH; Wong, J; Woo, YC; Wood, LS; Wu, CT; Wu, CY; Wu, D; Wu, G; Wu, J; Wu, K; Wu, M; Wu, Q; Wu, T; Wu, W; Wu, X; Wu, XT; Wu, Y; Xi, D; Xi, J; Xiang, W; Xiang, Y; Xiao, M; Xiao, Z; Xie, H; Xie, Q; Xie, S; Xie, X; Xing, M; Xing, YL; Xu, C; Xu, X; Xu, Y; Xu, Z; Xue, F; Xue, XD; Yaglioglu, HG; Yamada, H; Yamashita, M; Yan, W; Yan, Z; Yanardag, R; Yang, D; Yang, H; Yang, K; Yang, QQ; Yang, R; Yang, S; Yang, T; Yang, X; Yang, Y; Yao, H; Yao, Y; Yari, D; Yassin, MT; Ye, C; Ye, J; Ye, Q; Yildiz, EA; Ying, S; Yoon, H; Yu, D; Yu, K; Yu, N; Yu, PL; Yuan, C; Yuan, D; Yuan, LJ; Yuan, Z; Yuen, N; Zagatto, AM; Zakaria, Y; Zalewski, AM; Zamora, S; Zavorotinskaya, T; Zeid, JL; Zeinoun, T; Zeng, C; Zerby, HN; Zhan, X; Zhang, A; Zhang, D; Zhang, E; Zhang, F; Zhang, H; Zhang, J; Zhang, L; Zhang, M; Zhang, P; Zhang, Q; Zhang, QY; Zhang, RG; Zhang, S; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, CK; Zhao, H; Zhao, J; Zhao, K; Zhao, Q; Zhao, S; Zhao, T; Zhao, XQ; Zhao, Y; Zhao, Z; Zheng, J; Zheng, L; Zheng, Y; Zhou, B; Zhou, G; Zhou, L; Zhou, T; Zhou, X; Zhu, C; Zhu, J; Zhu, Y; Zhu, ZQ; Zhuang, T; Zimmermannova, O; Zin, NNINM; Zisimos, K; Zoghebi, KA; Zonder, JA; Zou, C; Zwirner, J | 1 |
| Giatromanolaki, A; Hasan, F; Koukourakis, MI; Kouroupi, M; Mitrakas, A; Pappa, A; Pouliliou, S | 1 |
| Armanet, C; Cadassou, O; Chettab, K; Cros-Perrial, E; Dumontet, C; Gudefin, L; Guitton, J; Jordheim, LP; Machon, C; Raza, MZ; Tozzi, MG | 1 |
| Chen, C; Fan, Y; Li, X; Pan, H; Zhou, Q | 1 |
| Xie, Y; Zhao, W | 1 |
| Chen, C; Chen, J; Gong, H; Li, W; Li, Y; Liu, C; Liu, H; Liu, M; Shi, R; Yuan, Y; Zhang, H; Zhang, Z | 1 |
| Akbay, EA; Behrens, C; Bernatchez, C; Byers, LA; Chen, R; Diao, L; Elamin, Y; Fan, YH; Federico, L; Gibbons, DL; Haymaker, C; Heymach, JV; Kadara, H; Karpinets, T; Khairullah, R; Le, X; Lee, WC; Li, J; McGrail, D; Munoz, IG; Negrao, MV; Nilsson, M; Parra, E; Patel, S; Reuben, A; Robichaux, J; Roth, J; Sepesi, B; Solis Soto, LM; Swisher, S; Vaporciyan, A; Wang, J; Wang, L; Wang, R; Wistuba, II; Wong, KK; Zhang, J; Zhu, M | 1 |
| Feng, F; Gao, C; Li, H; Liu, C; Liu, L; Sun, C; Zhou, C; Zhuang, J | 1 |
| Bu, P; Feng, Y; Guo, Y; Hu, X; Jiang, A; Li, D; Lin, Y; Liu, C; Liu, Y; Wang, X; Yan, H; Zhang, L; Zhang, S | 1 |
| Amin, SG; Belinsky, SA; Desai, DH; Do, K; Filipczak, PT; Hutt, JA; Juri, D; Picchi, MA; Tellez, CS | 1 |
| Ding, X; Li, D; Peng, Y; Wang, X; Wang, Y; Wu, Y; Yang, A; Yang, P; Yin, H; Yu, Y; Zhang, J; Zhang, R; Zhang, X | 1 |
| Chang, N; Che, Y; Jiang, J; Qiao, T; Wu, B; Wu, Y; Xiong, J; Xu, L; Zhang, J; Zhang, X; Zhang, Y; Zhou, Y | 1 |
| Pacheco, JM; Schenk, EL | 1 |
| Cang, S; Jia, G; Ma, P; Song, Z | 1 |
| Cheng, Y; Dong, H; Wang, M; Wang, S; Xu, H; Zhou, J | 1 |
| Ning, J; Okon, I; Satyanarayana, G; Song, P; Xu, S; Zhang, D; Zheng, X; Zou, MH | 1 |
| Khan, RIN; Malla, WA | 1 |
| Dang, C; Liu, S; Zhang, Y; Zhao, T | 1 |
| Chen, E; Dong, L; Jiang, C; Li, J; Li, X; Liu, P; Lu, B; Lu, Y; Qian, X; Qiu, Q; Yang, J; Ying, K | 1 |
| He, X; Hu, K; Jin, M; Li, G; Liu, W; Song, Y; Wu, X; Xiong, M; Zeng, Z; Zhang, Q; Zhao, D; Zhu, J | 1 |
| Chen, L; Lv, X; Ou-Yang, H; Ti, X; Wu, S; Xu, X; Zhang, Y; Zhao, F | 1 |
| Huang, Z; Shi, J; Shi, M; Wang, J; Zhang, H; Zheng, M; Zhou, H; Zhou, Y | 1 |
| Akiva, E; Gorzalczany, Y; Klein, O; Merimsky, O; Sagi-Eisenberg, R | 1 |
| Behrens, C; Dmitrovsky, E; Freemantle, S; Heymach, JV; Hong, S; Hu, S; Johnson, FM; Kawakami, M; Lee, JJ; Liu, X; Mino, B; Mustachio, LM; Myung, JH; Rodriguez-Canales, J; Roszik, J; Tong, P; Villalobos, PA; Wang, J; Wistuba, I; Zheng, L | 1 |
| Ahern, E; Bald, T; Barkauskas, DS; Boyle, GM; Chitsazan, A; Hölzel, M; Huntington, ND; Landsberg, J; Long, GV; Madore, J; Ngiow, SF; Rautela, J; Reinhardt, J; Schadendorf, D; Scolyer, RA; Smyth, MJ; Young, A | 1 |
| Dai, H; Gu, S; Sun, D; Zhang, Z | 1 |
| Du, Z; Jin, Y; Liu, J; Ren, D; Wang, H; Zhang, H | 1 |
| Bley, N; Chen, J; Dahl, A; Fuchs, T; Glaß, M; Haase, J; Huang, H; Hüttelmaier, S; Lederer, M; Müller, S; Posern, G; Singh, AK | 1 |
| Gao, Y; Han, Y; Jia, W; Li, B; Li, J; Qian, Z; Zhang, H; Zheng, H | 1 |
| Alcaraz, J; Baulida, J; Curto, J; Duch, P; Franco-Valls, H; García de Herreros, A; Peña, R; Sala, L; Stanisavljevic, J; Vergés, J | 1 |
| Kim, KC; Lee, JK | 1 |
| Dovat, S; Liu, J; Ma, Y; Nishizaki, T; Song, C; Song, J; Wu, L; Yang, D | 1 |
| Chen, SW; Hui, L; Liu, JF; Qin, WW; Sang, CY; Xu, XH | 1 |
| Bezuhly, M; Gebremeskel, S; Johnston, B; LeVatte, T; Liwski, RS | 1 |
| Behrens, C; Coombes, KR; Girard, L; Heymach, J; Hong, WK; Lee, JJ; Lin, HY; Minna, JD; Nilsson, MB; Riquelme, E; Simon, G; Suraokar, M; Wang, J; Wistuba, II | 1 |
| Balzarini, J; Peterson, MA; Shelton, JR | 1 |
| Fu, S; Guo, X; Wang, H; Wen, Y; Wu, Y; Yang, H; Yang, T | 1 |
| Assaraf, YG; Azzariti, A; Giovannetti, E; Jansen, G; Kathman, I; Paradiso, A; Peters, GJ; Porcelli, L; Scheffer, GL | 1 |
| Alexander, MP; Chabanet, TB; Clancy-Thompson, E; Croteau, W; Huang, YH; Mullins, DW; Perekslis, TJ; Turk, MJ | 1 |
| Hashemian, Z; Khayamian, T; Saraji, M; Shirani, MP | 1 |
| Dosaka-Akita, H; Kikuchi, J; Kinoshita, I; Nishimura, M; Oizumi, S; Sakakibara-Konishi, J; Shimizu, Y; Takashina, T | 1 |
| Baker, E; Brown, PM; Cooper, GJ; Loomes, KM; Middleditch, M; Payne, LS | 1 |
| Basu, I; Belbin, TJ; Cassera, MB; Dong, X; Evans, GB; Guha, C; Hemeon, I; Locker, J; Merino, EF; Schramm, VL | 1 |
| Calzetta, L; Cazzola, M; Facciolo, F; Matera, MG; Page, CP; Rendina, EA; Spina, D | 1 |
| Fujita, Y; Fukuoka, K; Gotoh, A; Kanno, T; Nakano, T; Nishizaki, T; Otsuki, T; Tabata, C | 1 |
| Dosaka-Akita, H; Kikuchi, E; Kikuchi, J; Kinoshita, I; Marquez, VE; Nishimura, M; Oizumi, S; Sakakibara-Konishi, J; Shimizu, Y; Takashina, T | 1 |
| Quan, F; Quan, W; Ramirez, M; Taylor, C; Vinogradov, M; Walker, P | 1 |
| Chung, HJ; Hong, JY; Jeong, LS; Kang, YJ; Kim, SJ; Lee, SK; Min, HY; Park, EJ; Shin, DH | 1 |
| Blay, J; Hoskin, DW; White, TD | 1 |
| Eberl, T; Fuchs, A; Gnaiger, E; Hengster, P; Kuznetsov, A; Lassnig, B; Margreiter, R; Rieger, G; Stadlmann, S | 1 |
| Goldman, Y; Peled, A; Shinitzky, M | 1 |
| Bar-Yehuda, S; Barer, F; Fishman, P; Madi, L; Multani, AS; Pathak, S | 1 |
| Anderson, LM; Budinger, JM; Giner-Sorolla, A; Greenbaum, JH; Last-Barney, K | 2 |
| Leithauser, MT; Liem, A; Miller, EC; Miller, JA; Stewart, BC | 1 |
| De Aizpurua, HJ; Griesmann, GE; Lambert, EH; Lennon, VA; Olivera, BM | 1 |
| Akedo, H; Horai, T; Inoue, H; Mukai, M; Nishikawa, S; Ohigashi, H; Shinkai, K; Takeda, Y | 1 |
| Fulton, AM | 1 |
| Altom, MG; Schultz, RM | 1 |
| Ades, EW; Altom, MG; DeLong, DC; Schultz, RM; Tang, JC | 1 |
| Akedo, H; Ishikawa, S; Nishihara, H; Shinkai, K | 1 |
11 review(s) available for adenosine and Lung Neoplasms
| Article | Year |
|---|---|
RNA Modifications and Epigenetics in Modulation of Lung Cancer and Pulmonary Diseases.
Topics: Adenosine; Animals; Epigenesis, Genetic; Humans; Lung Diseases; Lung Neoplasms; RNA; RNA Processing, Post-Transcriptional; RNA, Long Noncoding; RNA, Messenger | 2021 |
[Blocking Adenosine/A2AR Pathway for Cancer Therapy].
Topics: Adenosine; Adenosine A2 Receptor Antagonists; Humans; Lung Neoplasms; Receptor, Adenosine A2A; Tumor Microenvironment | 2022 |
Implications of m6A methylation and microbiota interaction in non-small cell lung cancer: From basics to therapeutics.
Topics: Adenosine; Carcinoma, Non-Small-Cell Lung; Humans; Lung Neoplasms; Methylation; Microbiota; RNA | 2022 |
Emerging role of N6-methyladenosine RNA methylation in lung diseases.
Topics: Adenosine; Asthma; Humans; Lung Diseases; Lung Neoplasms; Methylation; RNA; RNA, Messenger | 2022 |
RNA Epigenetics in Chronic Lung Diseases.
Topics: Adenosine; Epigenesis, Genetic; Humans; Lung Neoplasms; Methylation; RNA | 2022 |
Tumor intrinsic and extrinsic functions of CD73 and the adenosine pathway in lung cancer.
Topics: Adenosine; Carcinoma, Non-Small-Cell Lung; Humans; Immunotherapy; Killer Cells, Natural; Lung Neoplasms | 2023 |
Elevated Adenosine Dehydrogenase (ADH) and Positive Tuberculin Test Firstly Misdiagnosed as Tuberculous Pleural Effusion Finally Proved as Pleural Mesothelial Sarcoma by Thoracoscopic Biopsy Pathology: a Case Report and Literature Review.
Topics: Adenosine; Aged; Biopsy; Diagnosis, Differential; Diagnostic Errors; Humans; Lung Neoplasms; Male; Mesothelioma; Mesothelioma, Malignant; Oxidoreductases; Pleural Effusion; Sarcoma; Thoracoscopy; Tuberculin Test; Tuberculosis, Pleural | 2019 |
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
[Research Advances of m⁶A RNA Methylation in Non-small Cell Lung Cancer].
Topics: Adenosine; Carcinoma, Non-Small-Cell Lung; Humans; Lung Neoplasms; Methylation; Molecular Targeted Therapy; RNA, Messenger | 2020 |
The Important Role of N6-methyladenosine RNA Modification in Non-Small Cell Lung Cancer.
Topics: Adenosine; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Disease Progression; Drug Resistance, Neoplasm; Epigenesis, Genetic; Humans; Lung Neoplasms; Prognosis; RNA | 2021 |
m
Topics: Adenosine; Humans; Lung Neoplasms; Methylation; RNA; RNA, Long Noncoding; RNA, Messenger | 2021 |
5 trial(s) available for adenosine and Lung Neoplasms
| Article | Year |
|---|---|
Risk stratification of lung adenocarcinoma using a nomogram combined with ferroptosis-related LncRNAs and subgroup analysis with immune and N6-methyladenosine modification.
Topics: Adenocarcinoma of Lung; Adenosine; Ferroptosis; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Nomograms; Risk Assessment; RNA, Long Noncoding | 2022 |
Phase I Study of Taminadenant (PBF509/NIR178), an Adenosine 2A Receptor Antagonist, with or without Spartalizumab (PDR001), in Patients with Advanced Non-Small Cell Lung Cancer.
Topics: Adenosine; Alanine; Antibodies, Monoclonal, Humanized; Aspartate Aminotransferases; Carcinoma, Non-Small-Cell Lung; Humans; Lung Neoplasms; Purinergic P1 Receptor Antagonists; Tumor Microenvironment | 2022 |
Phase Ia/b, Open-Label, Multicenter Study of AZD4635 (an Adenosine A2A Receptor Antagonist) as Monotherapy or Combined with Durvalumab, in Patients with Solid Tumors.
Topics: Adenosine; Adenosine A2 Receptor Antagonists; Antineoplastic Combined Chemotherapy Protocols; B7-H1 Antigen; Carcinoma, Non-Small-Cell Lung; Humans; Lung Neoplasms; Male; Prostatic Neoplasms, Castration-Resistant; Purinergic P1 Receptor Antagonists; Receptor, Adenosine A2A | 2022 |
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
Administration of high-dose continuous infusion interleukin-2 to patients age 70 or over.
Topics: Adenosine; Aged; Aged, 80 and over; Aging; Capillary Leak Syndrome; Famotidine; Hemodynamics; Humans; Immunotherapy; Infusions, Intravenous; Interleukin-2; Kidney Neoplasms; Killer Cells, Lymphokine-Activated; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Melanoma; Time Factors; Treatment Outcome | 2005 |
110 other study(ies) available for adenosine and Lung Neoplasms
| Article | Year |
|---|---|
Gene and prognostic value of N6-methyladenosine (m6A) modification regulatory factors in lung adenocarcinoma.
Topics: Adenocarcinoma of Lung; Adenosine; Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Humans; Lung Neoplasms; Methyltransferases; Prognosis | 2022 |
N-6 methylation-related lncRNA is potential signature in lung adenocarcinoma and influences tumor microenvironment.
Topics: Adenocarcinoma of Lung; Adenosine; Aged; Computational Biology; DNA Methylation; Female; Humans; Lung Neoplasms; Male; Middle Aged; RNA, Long Noncoding; Transcriptome; Tumor Microenvironment | 2021 |
The landscape of m
Topics: Adenosine; Biomarkers, Tumor; Computational Biology; Disease Susceptibility; Gene Expression Regulation, Neoplastic; Genetic Variation; Humans; Lung Neoplasms; Methylation; Prognosis; RNA; Signal Transduction; Small Cell Lung Carcinoma | 2021 |
Multi-omics analysis of m
Topics: Adenocarcinoma of Lung; Adenosine; Aged; Biomarkers, Tumor; CTLA-4 Antigen; Female; Gene Expression Regulation, Neoplastic; Humans; Immunotherapy; Lung Neoplasms; Lymphocytes, Tumor-Infiltrating; Male; Prognosis; Tumor Microenvironment | 2021 |
The pathological tissue expression pattern and clinical significance of m6A-regulatory genes in non-small cell lung cancer.
Topics: Adenosine; Carcinoma, Non-Small-Cell Lung; ErbB Receptors; Genes, Regulator; Humans; Lung Neoplasms; Methyltransferases | 2022 |
m
Topics: Adenosine; Drug Resistance, Neoplasm; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Small Cell Lung Carcinoma | 2021 |
Survival-associated N
Topics: Adenine; Adenosine; Aged; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Databases, Genetic; Female; Gene Expression; Humans; Immunohistochemistry; Lung Neoplasms; Male; Methylation; Methyltransferases; Middle Aged; Principal Component Analysis; Prognosis; RNA, Messenger; ROC Curve; Survival Rate; Time Factors | 2021 |
An N
Topics: Adenocarcinoma of Lung; Adenosine; Biomarkers, Tumor; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms | 2022 |
m6A demethylation of cytidine deaminase APOBEC3B mRNA orchestrates arsenic-induced mutagenesis.
Topics: Adenosine; Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Arsenic; Carcinoma, Non-Small-Cell Lung; Cytidine Deaminase; Demethylation; Humans; Lung Neoplasms; Minor Histocompatibility Antigens; Mutagenesis; RNA, Messenger | 2022 |
N6-methyladenosine-induced SVIL antisense RNA 1 restrains lung adenocarcinoma cell proliferation by destabilizing E2F1.
Topics: A549 Cells; Adenocarcinoma of Lung; Adenosine; Cell Proliferation; E2F1 Transcription Factor; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Membrane Proteins; Methyltransferases; Microfilament Proteins; RNA Stability; RNA, Antisense; RNA, Long Noncoding; Tumor Cells, Cultured | 2022 |
Pharmacological Study of A3 Adenosine Receptor agonist (AB Meca) in Xenograft Lung Cancer Model in Mice through In Silico and In Vivo Approach: Targeting TNF-α.
Topics: Adenosine; Adenosine A3 Receptor Agonists; Animals; Disease Models, Animal; Doxorubicin; Heterografts; Humans; Lung Neoplasms; Mice; Molecular Docking Simulation; Rats; Tumor Necrosis Factor-alpha | 2022 |
Insights into the negative regulation of EGFR upon the binding of an allosteric inhibitor.
Topics: Adenosine; Adenosine Triphosphate; Allosteric Regulation; Carcinoma, Non-Small-Cell Lung; ErbB Receptors; Humans; Lung Neoplasms; Mutation; Phosphates; Protein Kinase Inhibitors | 2022 |
Correlation analysis of m6A-modified regulators with immune microenvironment infiltrating cells in lung adenocarcinoma.
Topics: Adenocarcinoma of Lung; Adenosine; Humans; Lung Neoplasms; Lymphocytes, Tumor-Infiltrating; Methylation; RNA; RNA Processing, Post-Transcriptional; Tumor Microenvironment | 2022 |
Adenosine Pathway in NSCLC With Molecular Drivers: Can Oncogene Addiction Translate Into Immune Addiction?
Topics: Adenosine; Carcinoma, Non-Small-Cell Lung; ErbB Receptors; Humans; Lung Neoplasms; Oncogene Addiction | 2022 |
In Response.
Topics: Adenosine; ErbB Receptors; Humans; Lung Neoplasms | 2022 |
Construction and validation of a novel prognostic model for lung squamous cell cancer based on N6-methyladenosine-related genes.
Topics: Adenosine; Biomarkers, Tumor; Epithelial Cells; Humans; Lung; Lung Neoplasms; Prognosis | 2022 |
Methyltransferase 3, N6-adenosine-methyltransferase complex catalytic subunit-induced long intergenic non-protein coding RNA 1833 N6-methyladenosine methylation promotes the non-small cell lung cancer progression via regulating heterogeneous nuclear ribon
Topics: Adenosine; Animals; Carcinoma, Non-Small-Cell Lung; Catalytic Domain; Heterogeneous-Nuclear Ribonucleoprotein Group A-B; Humans; Lung Neoplasms; Methylation; Methyltransferases; Mice; RNA, Long Noncoding | 2022 |
CD73/Adenosine Pathway Involvement in the Interaction of Non-Small Cell Lung Cancer Stem Cells and Bone Cells in the Pre-Metastatic Niche.
Topics: Adenosine; Carcinoma, Non-Small-Cell Lung; Humans; Lung Neoplasms; Neoplastic Stem Cells; Receptor, Adenosine A2A | 2022 |
[Comprehensive Analysis of the Relationship between m6A Methylation Patterns and Immune Microenvironment in Lung Adenocarcinoma].
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adenosine; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Methylation; Tumor Microenvironment | 2022 |
N6-methyladenosine (m6A) regulator expression pattern correlates with the immune landscape in lung adenocarcinoma.
Topics: Adenocarcinoma of Lung; Adenosine; Humans; Lung Neoplasms; Tumor Microenvironment | 2022 |
Suppression of tumor progression by thioredoxin-interacting protein-dependent adenosine 2B receptor degradation in a PLAG-treated Lewis lung carcinoma-1 model of non-small cell lung cancer.
Topics: Adenosine; Animals; Carcinoma, Lewis Lung; Carcinoma, Non-Small-Cell Lung; Carrier Proteins; Diglycerides; Lung Neoplasms; Mice; Receptors, Purinergic P1; Thioredoxins; Tumor Microenvironment | 2022 |
The prognostic value of N6-methyladenosine RBM15 regulators in lung adenocarcinoma.
Topics: Adenocarcinoma of Lung; Adenosine; Animals; Humans; Lung Neoplasms; Mammals; Prognosis; RNA-Binding Proteins; RNA, Messenger; RNA, Small Interfering | 2022 |
Engineered natural killer cells impede the immunometabolic CD73-adenosine axis in solid tumors.
Topics: Adenosine; Carcinoma, Non-Small-Cell Lung; Humans; Immunotherapy; Killer Cells, Natural; Lung Neoplasms | 2022 |
Anesthetic propofol enhances cisplatin-sensitivity of non-small cell lung cancer cells through N6-methyladenosine-dependently regulating the miR-486-5p/RAP1-NF-κB axis.
Topics: Adenosine; Anesthetics; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Cisplatin; Drug Resistance, Neoplasm; Humans; Lung Neoplasms; MicroRNAs; NF-kappa B; Propofol | 2022 |
Metabolic reprogramming by adenosine antagonism and implications in non-small cell lung cancer therapy.
Topics: Adenosine; Animals; Carcinoma, Non-Small-Cell Lung; Lung Neoplasms; Receptor, Adenosine A2A; Receptor, Adenosine A2B; Tumor Microenvironment | 2022 |
N6-Methyladenosine Reader YTHDF2 Enhances Non-Small-Cell Lung Cancer Cell Proliferation and Metastasis through Mediating circ_SFMBT2 Degradation.
Topics: Adenosine; Carcinoma, Non-Small-Cell Lung; Cell Movement; Cell Proliferation; Humans; Lung Neoplasms; Protein Serine-Threonine Kinases; Repressor Proteins; RNA; RNA-Binding Proteins; Transcription Factors; Tumor Suppressor Proteins | 2022 |
A novel algorithm for lung adenocarcinoma based on N6 methyladenosine-related immune long noncoding RNAs as a reliable biomarker for predicting survival outcomes and selecting sensitive anti-tumor therapies.
Topics: Adenocarcinoma; Adenosine; Algorithms; Antineoplastic Agents; Humans; Lung; Lung Neoplasms; Prognosis; RNA, Long Noncoding; Tumor Microenvironment | 2022 |
Protein kinase inhibitor ceritinib blocks ectonucleotidase CD39 - a promising target for cancer immunotherapy.
Topics: Adenosine; Adenosine Triphosphate; Antigens, CD; Antineoplastic Agents; Apyrase; Carcinoma, Non-Small-Cell Lung; Humans; Immunotherapy; Leukocytes, Mononuclear; Lung Neoplasms; Protein Kinase Inhibitors; Pyrimidines; Receptor Protein-Tyrosine Kinases; Sulfones; Tumor Microenvironment | 2022 |
LRTCLS: low-rank tensor completion with Laplacian smoothing regularization for unveiling the post-transcriptional machinery of N6-methylation (m6A)-mediated diseases.
Topics: Adenosine; Alternative Splicing; Carcinoma, Non-Small-Cell Lung; COVID-19; Humans; Lung Neoplasms; Methylation; MicroRNAs; RNA-Binding Proteins; RNA, Circular | 2022 |
Effects of N6-Methyladenosine Regulators on LAG3 and Immune Infiltrates in Lung Adenocarcinoma.
Topics: Adenocarcinoma of Lung; Adenosine; Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Antigens, CD; Humans; Lung Neoplasms; Lymphocyte Activation Gene 3 Protein; Prognosis; RNA-Binding Proteins; Tumor Microenvironment; Ubiquitin-Protein Ligases | 2022 |
RNA modification writer expression profiles predict clinical outcomes and guide neoadjuvant immunotherapy in non-small cell lung cancer.
Topics: Adenosine; Carcinoma, Non-Small-Cell Lung; Humans; Immune Checkpoint Inhibitors; Immunologic Factors; Immunotherapy; Inosine; Lung Neoplasms; Neoadjuvant Therapy; Prognosis; RNA; Tumor Microenvironment | 2022 |
Methylation of N6 adenosine-related long noncoding RNA: effects on prognosis and treatment in 'driver-gene-negative' lung adenocarcinoma.
Topics: Adenocarcinoma; Adenosine; Humans; Lung; Lung Neoplasms; Methylation; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; RNA, Long Noncoding; Tumor Microenvironment | 2023 |
Study on the prognosis, immune and drug resistance of m6A-related genes in lung cancer.
Topics: Adenosine; Afatinib; Crizotinib; Dasatinib; Drug Resistance; Erlotinib Hydrochloride; Etoposide; Humans; Lapatinib; Lung Neoplasms; Tumor Microenvironment; Ubiquitin-Protein Ligases | 2022 |
PEDF inhibits non‑small cell lung cancer proliferation by suppressing autophagy through downregulation of AMPK‑ULK1 signaling.
Topics: Adenosine; AMP-Activated Protein Kinases; Autophagy; Autophagy-Related Protein-1 Homolog; Carcinoma, Non-Small-Cell Lung; Cell Proliferation; Down-Regulation; Humans; Intracellular Signaling Peptides and Proteins; Lactate Dehydrogenases; Lung Neoplasms; Microtubule-Associated Proteins; Signal Transduction | 2022 |
Gene expression pattern of adenosine receptors in lung tumors.
Topics: Adenosine; Gene Expression; Humans; Lung Neoplasms; Receptors, Purinergic P1 | 2023 |
Impact of
Topics: Adenosine; COVID-19; COVID-19 Drug Treatment; Humans; Lung Neoplasms; Male; Mutation; Prognosis; Prostatic Neoplasms; SARS-CoV-2; Serine Endopeptidases | 2022 |
Potential impact of WTAP and YTHDF2 on tumor immunity in lung adenocarcinoma.
Topics: Adenocarcinoma of Lung; Adenosine; Cell Cycle Proteins; Humans; Lung Neoplasms; Methyltransferases; RNA Splicing Factors; RNA-Binding Proteins; Transcription Factors | 2022 |
Somatic A-to-I RNA-edited RHOA isoform 2 specific-R176G mutation promotes tumor progression in lung adenocarcinoma.
Topics: Adenocarcinoma of Lung; Adenosine; Cell Line, Tumor; Cell Proliferation; Gene Expression Regulation, Neoplastic; Guanosine Triphosphate; Humans; Inosine; Lung Neoplasms; Mutation; Protein Isoforms; Proteomics; rhoA GTP-Binding Protein; RNA | 2023 |
METTL3 enhances pancreatic ductal adenocarcinoma progression and gemcitabine resistance through modifying DDX23 mRNA N6 adenosine methylation.
Topics: Adenosine; Animals; Carcinoma, Pancreatic Ductal; DEAD-box RNA Helicases; Gemcitabine; Humans; Lung Neoplasms; Methylation; Methyltransferases; Pancreatic Neoplasms; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; RNA, Messenger | 2023 |
Improving combination therapies: targeting A2B-adenosine receptor to modulate metabolic tumor microenvironment and immunosuppression.
Topics: Adenosine; Animals; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Humans; Immunosuppression Therapy; Lung Neoplasms; Mice; Phosphates; Receptor, Adenosine A2B; Tumor Microenvironment | 2023 |
Downregulation of N6-methyladenosine-modified LINC00641 promotes EMT, but provides a ferroptotic vulnerability in lung cancer.
Topics: Adenocarcinoma of Lung; Adenosine; Cell Nucleus; Down-Regulation; Humans; Lung Neoplasms | 2023 |
YTHDF2 negatively correlates with tumor immune infiltration in small cell lung cancer.
Topics: Adenosine; CD8-Positive T-Lymphocytes; Humans; Lung Neoplasms; Prognosis; RNA-Binding Proteins; Small Cell Lung Carcinoma; Transcription Factors; Tumor Microenvironment | 2023 |
N6-methyladenosine-regulated ADIRF impairs lung adenocarcinoma metastasis and serves as a potential prognostic biomarker.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adenosine; Biomarkers; Humans; Lung Neoplasms; Prognosis | 2023 |
Increased interleukin-6/C-reactive protein levels are associated with the upregulation of the adenosine pathway and serve as potential markers of therapeutic resistance to immune checkpoint inhibitor-based therapies in non-small cell lung cancer.
Topics: Adenosine; C-Reactive Protein; Carcinoma, Non-Small-Cell Lung; Drug Resistance, Neoplasm; Humans; Immune Checkpoint Inhibitors; Interleukin-6; Lung Neoplasms; Tumor Microenvironment; Up-Regulation | 2023 |
Dissecting the m
Topics: A549 Cells; Adenosine; Afatinib; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Drug Resistance, Neoplasm; Humans; Lung Neoplasms | 2020 |
ALKBH5-m
Topics: Adenocarcinoma of Lung; Adenosine; AlkB Homolog 5, RNA Demethylase; Animals; Cell Proliferation; Forkhead Box Protein M1; Humans; Hypoxia; Lung Neoplasms; Mice; Neoplasm Invasiveness; Signal Transduction | 2020 |
N6-methyladenosine induced miR-143-3p promotes the brain metastasis of lung cancer via regulation of VASH1.
Topics: Adenosine; Animals; Blood-Brain Barrier; Brain Neoplasms; Cell Cycle Proteins; Cell Line, Tumor; Disease Models, Animal; Disease Progression; Epithelial-Mesenchymal Transition; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Mice; MicroRNAs; Models, Biological; Neovascularization, Pathologic; RNA Interference; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2019 |
Immune signature of T follicular helper cells predicts clinical prognostic and therapeutic impact in lung squamous cell carcinoma.
Topics: Adenosine; Aged; AlkB Homolog 5, RNA Demethylase; Antineoplastic Agents, Immunological; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Datasets as Topic; Female; Gene Expression Regulation, Neoplastic; Heterogeneous-Nuclear Ribonucleoprotein Group C; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Lymphocytes, Tumor-Infiltrating; Male; Methylation; Methyltransferases; Middle Aged; Prognosis; RNA-Binding Proteins; RNA-Seq; T Follicular Helper Cells; Transcriptome | 2020 |
N
Topics: A549 Cells; Adenosine; AlkB Homolog 5, RNA Demethylase; Animals; Carcinogenesis; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Disease Progression; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, Nude; RNA Stability; RNA, Messenger; Tissue Inhibitor of Metalloproteinase-3 | 2020 |
N6-Methyladenosine Regulates the Expression and Secretion of TGFβ1 to Affect the Epithelial-Mesenchymal Transition of Cancer Cells.
Topics: 5' Untranslated Regions; Adenosine; Animals; Cell Movement; Down-Regulation; Epithelial-Mesenchymal Transition; Gene Knockdown Techniques; HeLa Cells; Humans; Lung Neoplasms; Methyltransferases; Mice; Peptide Chain Elongation, Translational; Protein Biosynthesis; Protein Stability; Snail Family Transcription Factors; Transforming Growth Factor beta1 | 2020 |
Adenosine A2A receptor activation reduces brain metastasis via SDF-1/CXCR4 axis and protecting blood-brain barrier.
Topics: Adenosine; Adenosine A2 Receptor Agonists; Animals; Benzylamines; Blood-Brain Barrier; Brain Neoplasms; Cell Line, Tumor; Cell Movement; Chemokine CXCL12; Cyclams; Heterocyclic Compounds; Humans; Lung Neoplasms; Mice, Inbred BALB C; Mice, Nude; Phenethylamines; Receptor, Adenosine A2A; Receptors, CXCR4; Xenograft Model Antitumor Assays | 2020 |
Expression and Prognostic Significance of m6A-Related Genes in Lung Adenocarcinoma.
Topics: Adenocarcinoma of Lung; Adenosine; Cohort Studies; Disease-Free Survival; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Prognosis; RNA, Messenger | 2020 |
Simvastatin is beneficial to lung cancer progression by inducing METTL3-induced m6A modification on EZH2 mRNA.
Topics: A549 Cells; Adenosine; Antineoplastic Agents; Cell Proliferation; Dose-Response Relationship, Drug; Enhancer of Zeste Homolog 2 Protein; Epithelial-Mesenchymal Transition; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lung Neoplasms; Methyltransferases; RNA, Messenger; Simvastatin; Tumor Cells, Cultured | 2020 |
FTSJ1 regulates tRNA 2'-O-methyladenosine modification and suppresses the malignancy of NSCLC via inhibiting DRAM1 expression.
Topics: A549 Cells; Adenosine; Animals; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Movement; Cell Proliferation; Down-Regulation; Female; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Membrane Proteins; Methyltransferases; Mice, Inbred BALB C; Mice, Nude; Neoplasm Invasiveness; Nuclear Proteins; RNA, Transfer; Signal Transduction; Tumor Burden; Tumor Suppressor Proteins | 2020 |
Ectonucleotidase CD73 and CD39 expression in non-small cell lung cancer relates to hypoxia and immunosuppressive pathways.
Topics: 5'-Nucleotidase; Adenosine; Adult; Aged; Aged, 80 and over; Antigens, CD; Apyrase; B7-H1 Antigen; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Female; Gene Expression Regulation, Neoplastic; Humans; Hypoxia; Immune Tolerance; Lung Neoplasms; Male; Middle Aged | 2020 |
Enhanced migration of breast and lung cancer cells deficient for cN-II and CD73 via COX-2/PGE2/AKT axis regulation.
Topics: 5'-Nucleotidase; Adenosine; Animals; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Cyclooxygenase 2; Dinoprostone; Female; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Mice; Models, Biological; Nucleotides; Proto-Oncogene Proteins c-akt; RNA, Messenger; Signal Transduction | 2021 |
KIAA1429 promotes the progression of lung adenocarcinoma by regulating the m6A level of MUC3A.
Topics: A549 Cells; Adenocarcinoma of Lung; Adenosine; Cell Movement; Cell Proliferation; Databases, Genetic; Female; G1 Phase Cell Cycle Checkpoints; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Methylation; Middle Aged; Mucin-3; Neoplasm Invasiveness; Neoplasm Staging; RNA Processing, Post-Transcriptional; RNA-Binding Proteins; Signal Transduction; Tumor Burden | 2021 |
EZH2 inhibitors reverse resistance to gefitinib in primary EGFR wild-type lung cancer cells.
Topics: Adenosine; Adult; Aged; Animals; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Cycle; Cell Line, Tumor; Cell Movement; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Enhancer of Zeste Homolog 2 Protein; Female; Gefitinib; Gene Expression Regulation, Neoplastic; Genes, erbB-1; Humans; Indazoles; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Middle Aged; Neoplasm Invasiveness; Neoplasm Proteins; Protein Kinase Inhibitors; Pyridones; RNA Interference; RNA, Neoplasm; RNA, Small Interfering; Signal Transduction | 2020 |
Characterization of the Immune Landscape of EGFR-Mutant NSCLC Identifies CD73/Adenosine Pathway as a Potential Therapeutic Target.
Topics: Adenocarcinoma of Lung; Adenosine; Animals; Carcinoma, Non-Small-Cell Lung; ErbB Receptors; Lung Neoplasms; Mice; Mutation; Tumor Microenvironment | 2021 |
Gene signatures of 6-methyladenine regulators in women with lung adenocarcinoma and development of a risk scoring system: a retrospective study using the cancer genome atlas database.
Topics: Adenocarcinoma of Lung; Adenosine; Databases, Genetic; DNA Copy Number Variations; Early Detection of Cancer; Female; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Middle Aged; Neoplasm Staging; Proportional Hazards Models; Risk Assessment; RNA Processing, Post-Transcriptional; Survival Rate; Transcriptome | 2021 |
N
Topics: Adenosine; Animals; Apoptosis; Biomarkers, Tumor; Cell Nucleus; Cell Proliferation; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Female; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Mice; Mice, Inbred NOD; Mice, SCID; RNA, Long Noncoding; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2021 |
Chromatin remodeling by the histone methyltransferase EZH2 drives lung pre-malignancy and is a target for cancer prevention.
Topics: Adenosine; Adenosylhomocysteinase; Animals; Benzamides; Biphenyl Compounds; Cell Proliferation; Chromatin Assembly and Disassembly; CpG Islands; DNA Methylation; Enhancer of Zeste Homolog 2 Protein; Enzyme Inhibitors; Epigenesis, Genetic; Epithelial Cells; Female; Histone Code; Histone Methyltransferases; Histone-Lysine N-Methyltransferase; Histones; Humans; Lung Neoplasms; Mice; Morpholines; Neoplasms; Phenotype; Pyridones; Transcriptome | 2021 |
RNA m6A methylation orchestrates cancer growth and metastasis via macrophage reprogramming.
Topics: Adenosine; Animals; Base Sequence; Cell Line, Tumor; Cell Polarity; Cell Proliferation; Cellular Reprogramming; Cytokines; Gene Deletion; Gene Expression Regulation; Lung Neoplasms; Macrophages; Melanoma, Experimental; Methylation; Methyltransferases; Mice, Knockout; Myeloid Cells; Neoplasm Metastasis; NF-kappa B; Programmed Cell Death 1 Receptor; Repressor Proteins; RNA-Binding Proteins; RNA, Neoplasm; STAT3 Transcription Factor; T-Lymphocytes, Regulatory; Tumor Microenvironment | 2021 |
METTL3-mediated m
Topics: Adenocarcinoma of Lung; Adenosine; Animals; Cell Line, Tumor; Cell Proliferation; F-Box-WD Repeat-Containing Protein 7; Heterografts; Humans; Lung Neoplasms; Methyltransferases; Mice; Mice, Inbred BALB C; Mice, Nude; RNA, Messenger | 2021 |
CD73 and Adenosine Receptor Signaling as a Potential Therapeutic Target in EGFR-Mutated NSCLC.
Topics: Adenosine; Carcinoma, Non-Small-Cell Lung; ErbB Receptors; Humans; Lung Neoplasms; Receptors, Purinergic P1 | 2021 |
Exosomal miR-4443 promotes cisplatin resistance in non-small cell lung carcinoma by regulating FSP1 m6A modification-mediated ferroptosis.
Topics: Adenosine; Animals; Antineoplastic Agents; Apoptosis; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Cell Movement; Cell Proliferation; Cisplatin; DNA Methylation; Drug Resistance, Neoplasm; Epigenesis, Genetic; Exosomes; Ferroptosis; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, Nude; MicroRNAs; Prognosis; S100 Calcium-Binding Protein A4; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2021 |
Suppression of m6A mRNA modification by DNA hypermethylated ALKBH5 aggravates the oncological behavior of KRAS mutation/LKB1 loss lung cancer.
Topics: Adenosine; AlkB Homolog 5, RNA Demethylase; AMP-Activated Protein Kinase Kinases; Cell Line, Tumor; DNA Methylation; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Mutation; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins p21(ras); RNA, Messenger; Transfection | 2021 |
METTL3‑mediated m6A modification of Bcl‑2 mRNA promotes non‑small cell lung cancer progression.
Topics: A549 Cells; Adenosine; Animals; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Disease Progression; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Male; Methyltransferases; Mice; Middle Aged; Neoplasm Transplantation; Proto-Oncogene Proteins c-bcl-2; RNA, Messenger; Survival Analysis | 2021 |
LCAT3, a novel m6A-regulated long non-coding RNA, plays an oncogenic role in lung cancer via binding with FUBP1 to activate c-MYC.
Topics: Adenosine; Animals; Carcinogenesis; Cell Line, Tumor; DNA-Binding Proteins; Female; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Mice, Inbred BALB C; Neoplasm Invasiveness; Prognosis; Proto-Oncogene Proteins c-myc; RNA-Binding Proteins; RNA, Long Noncoding; Up-Regulation | 2021 |
Cigarette smoking induces aberrant N
Topics: A549 Cells; Adenosine; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cigarette Smoking; Death-Associated Protein Kinases; Disease Progression; Down-Regulation; Gene Expression Regulation; HEK293 Cells; Humans; Lung Neoplasms; NF-kappa B; Nicotiana; Oncogenes; RNA, Messenger; Signal Transduction | 2021 |
Microarray analysis of genes with differential expression of m6A methylation in lung cancer.
Topics: Adenosine; Biomarkers, Tumor; DNA Methylation; Epigenome; Epigenomics; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Regulatory Networks; Humans; Lung Neoplasms; Oligonucleotide Array Sequence Analysis; Transcriptome | 2021 |
Characteristic of molecular subtypes in lung adenocarcinoma based on m6A RNA methylation modification and immune microenvironment.
Topics: Adenocarcinoma of Lung; Adenosine; Biomarkers, Tumor; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Methylation; Prognosis; RNA Processing, Post-Transcriptional; Survival Rate; Transcriptome; Tumor Microenvironment | 2021 |
Mast cells are directly activated by contact with cancer cells by a mechanism involving autocrine formation of adenosine and autocrine/paracrine signaling of the adenosine A3 receptor.
Topics: A549 Cells; Adenosine; Autocrine Communication; Cell Membrane; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Humans; Interleukin-8; Lung Neoplasms; Mast Cells; Pancreatic Neoplasms; Paracrine Communication; Phosphatidylinositol 3-Kinase; Phosphorylation; Proto-Oncogene Proteins c-akt; Receptor, Adenosine A3; RNA Interference; Signal Transduction; Time Factors; Transfection; Tumor Microenvironment | 2017 |
Next-Generation CDK2/9 Inhibitors and Anaphase Catastrophe in Lung Cancer.
Topics: Adenosine; Anaphase; Animals; Apoptosis; Apoptosis Regulatory Proteins; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Centrosome; Cyclin-Dependent Kinase 2; Gene Knockdown Techniques; Humans; Intracellular Signaling Peptides and Proteins; Lung Neoplasms; Male; Mice; Phosphoproteins; Phosphorylation; Protein Kinase Inhibitors; Proto-Oncogene Proteins p21(ras); Purines; Roscovitine; Signal Transduction | 2017 |
Targeting Adenosine in BRAF-Mutant Melanoma Reduces Tumor Growth and Metastasis.
Topics: 5'-Nucleotidase; Adenosine; Animals; Drug Therapy, Combination; GPI-Linked Proteins; Humans; Imidazoles; Lung Neoplasms; MAP Kinase Kinase 1; Melanoma; Mice; Mice, Inbred C57BL; Mice, Knockout; Molecular Targeted Therapy; Mutation; Oximes; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Pyridones; Pyrimidinones; Receptor, Adenosine A2A; Skin Neoplasms | 2017 |
N
Topics: Adenosine; Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Apoptosis; Arsenites; Cell Cycle Proteins; Cell Proliferation; Cell Transformation, Neoplastic; Cells, Cultured; Dose-Response Relationship, Drug; Epithelial Cells; Gene Expression Regulation, Neoplastic; Humans; Lung; Lung Neoplasms; Methyltransferases; MicroRNAs; Nuclear Proteins; Phenotype; RNA Splicing Factors; Signal Transduction; Sodium Compounds; Time Factors | 2018 |
m
Topics: Adenosine; Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Carcinoma, Squamous Cell; Cell Line, Tumor; Disease Progression; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Humans; Kruppel-Like Transcription Factors; Lung Neoplasms; Oncogenes; Prognosis; RNA Stability; RNA, Messenger; RNA, Neoplasm | 2018 |
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner.
Topics: Adenosine; Animals; Cell Line, Tumor; Disease-Free Survival; Female; Gene Expression Regulation, Neoplastic; Hep G2 Cells; Humans; Liver Neoplasms; Lung Neoplasms; Male; Mice; MicroRNAs; Ovarian Neoplasms; RNA-Binding Proteins; Serum Response Factor; Xenograft Model Antitumor Assays | 2019 |
The m6A demethylase FTO promotes the growth of lung cancer cells by regulating the m6A level of USP7 mRNA.
Topics: Adenosine; Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; RNA, Messenger; Ubiquitin-Specific Peptidase 7 | 2019 |
Abrogation of myofibroblast activities in metastasis and fibrosis by methyltransferase inhibition.
Topics: Adenosine; Animals; Breast Neoplasms; Cancer-Associated Fibroblasts; Cell Line, Tumor; Cell Transdifferentiation; Cells, Cultured; Disease Models, Animal; Enzyme Inhibitors; Epigenesis, Genetic; Female; Gene Deletion; Humans; Idiopathic Pulmonary Fibrosis; Lung Neoplasms; Methyltransferases; Mice; Myofibroblasts; Snail Family Transcription Factors; Transforming Growth Factor beta; Tumor Microenvironment; Xenograft Model Antitumor Assays | 2019 |
DZNep, inhibitor of S-adenosylhomocysteine hydrolase, down-regulates expression of SETDB1 H3K9me3 HMTase in human lung cancer cells.
Topics: Adenosine; Adenosylhomocysteinase; Cell Death; Cell Line, Tumor; Down-Regulation; Enzyme Inhibitors; Histone-Lysine N-Methyltransferase; Histones; Humans; Lung; Lung Neoplasms; Methylation; Promoter Regions, Genetic; Protein Methyltransferases | 2013 |
Induction of senescence by adenosine suppressing the growth of lung cancer cells.
Topics: Adenosine; Animals; Antineoplastic Agents; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cellular Senescence; Cyclin-Dependent Kinase Inhibitor p21; Female; Humans; Lung; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Tumor Suppressor Protein p53 | 2013 |
DPMA, a deoxypodophyllotoxin derivative, induces apoptosis and anti-angiogenesis in non-small cell lung cancer A549 cells.
Topics: Adenosine; Apoptosis; bcl-2-Associated X Protein; Carcinoma, Non-Small-Cell Lung; CDC2 Protein Kinase; Cell Cycle Checkpoints; Cell Line, Tumor; Drugs, Chinese Herbal; Human Umbilical Vein Endothelial Cells; Humans; Lung Neoplasms; Neovascularization, Physiologic; Podophyllotoxin; Signal Transduction; Tumor Suppressor Protein p53; Vascular Endothelial Growth Factor A | 2013 |
The reversible P2Y12 inhibitor ticagrelor inhibits metastasis and improves survival in mouse models of cancer.
Topics: Adenosine; Animals; Antineoplastic Agents; Bone Neoplasms; Drug Screening Assays, Antitumor; Female; Gene Expression; Liver Neoplasms; Lung Neoplasms; Mammary Neoplasms, Experimental; Melanoma, Experimental; Mice, Inbred BALB C; Mice, Inbred C57BL; Neoplasm Transplantation; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2Y12; Ticagrelor | 2015 |
VEGF/VEGFR-2 upregulates EZH2 expression in lung adenocarcinoma cells and EZH2 depletion enhances the response to platinum-based and VEGFR-2-targeted therapy.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adenosine; Animals; Antineoplastic Agents; Carboplatin; Cell Line, Tumor; Cell Proliferation; Cisplatin; Enhancer of Zeste Homolog 2 Protein; Female; Gene Expression Regulation, Neoplastic; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Mice, Nude; MicroRNAs; Molecular Targeted Therapy; Polycomb Repressive Complex 2; Signal Transduction; Up-Regulation; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2; Xenograft Model Antitumor Assays | 2014 |
Discovery of a nanomolar inhibitor of lung adenocarcinoma in vitro.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adenosine; Antineoplastic Agents; Binding Sites; Bone Morphogenetic Protein Receptors, Type I; Catalytic Domain; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Evaluation, Preclinical; Drug Screening Assays, Antitumor; HeLa Cells; Humans; Lung Neoplasms; Molecular Docking Simulation; Structure-Activity Relationship | 2014 |
Facile and label-free detection of lung cancer biomarker in urine by magnetically assisted surface-enhanced Raman scattering.
Topics: Adenosine; Biomarkers, Tumor; Gold; Humans; Lung Neoplasms; Magnetics; Metal Nanoparticles; Silver; Spectrum Analysis, Raman; Surface Properties | 2014 |
The EGFR pathway regulates BCRP expression in NSCLC cells: role of erlotinib.
Topics: Adenosine; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Membrane; Chromones; Cytoplasm; Diketopiperazines; ErbB Receptors; Erlotinib Hydrochloride; Heterocyclic Compounds, 4 or More Rings; Humans; Lung Neoplasms; Morpholines; Neoplasm Proteins; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Quinazolines; Signal Transduction | 2014 |
Melanoma Induces, and Adenosine Suppresses, CXCR3-Cognate Chemokine Production and T-cell Infiltration of Lungs Bearing Metastatic-like Disease.
Topics: Adenosine; Animals; CD8-Positive T-Lymphocytes; Chemokines; Cytokines; Disease Models, Animal; Humans; Ligands; Lung Neoplasms; Lymphocytes, Tumor-Infiltrating; Melanoma; Melanoma, Experimental; Mice, Knockout; Neoplasm Metastasis; Receptors, CXCR3; Signal Transduction; T-Lymphocytes; Tumor Burden | 2015 |
Aptasensor based on fluorescence resonance energy transfer for the analysis of adenosine in urine samples of lung cancer patients.
Topics: Adenosine; Aptamers, Nucleotide; Biosensing Techniques; Fluorescence; Fluorescence Resonance Energy Transfer; G-Quadruplexes; Humans; Limit of Detection; Lung Neoplasms; Molecular Dynamics Simulation; Polymers; Pyrroles; Quantum Dots | 2016 |
Combined inhibition of EZH2 and histone deacetylases as a potential epigenetic therapy for non-small-cell lung cancer cells.
Topics: Acetylation; Adenosine; Animals; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Cyclin A; Cyclin-Dependent Kinase Inhibitor p27; Drug Synergism; Enhancer of Zeste Homolog 2 Protein; Epigenesis, Genetic; ErbB Receptors; Female; Histone Deacetylase Inhibitors; Histone Deacetylases; Histones; Humans; Hydroxamic Acids; Lung Neoplasms; Methylation; Mice; Mice, Inbred BALB C; Mutation; Phosphorylation; Polycomb Repressive Complex 2; Signal Transduction; Vorinostat; Xenograft Model Antitumor Assays | 2016 |
Mapping of the ATP-binding domain of human fructosamine 3-kinase-related protein by affinity labelling with 5'-[p-(fluorosulfonyl)benzoyl]adenosine.
Topics: Adenosine; Adenosine Triphosphate; Affinity Labels; Binding Sites; Cell Line, Tumor; DNA Primers; Glycosylation; Humans; Kanamycin Kinase; Lung Neoplasms; Muramidase; Phosphotransferases (Alcohol Group Acceptor); Protein Kinases; Recombinant Proteins; Reverse Transcriptase Polymerase Chain Reaction; Trypsin | 2008 |
Growth and metastases of human lung cancer are inhibited in mouse xenografts by a transition state analogue of 5'-methylthioadenosine phosphorylase.
Topics: Adenine; Adenosine; Animals; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Deoxyadenosines; Humans; Lung Neoplasms; Mice; Mice, Nude; Neoplasm Metastasis; Neoplasm Transplantation; Purine-Nucleoside Phosphorylase; Pyrrolidines; S-Adenosylmethionine; Thionucleosides; Transplantation, Heterologous; Tumor Suppressor Proteins; Xenograft Model Antitumor Assays | 2011 |
Pharmacological characterization of adenosine receptors on isolated human bronchi.
Topics: Adenosine; Adenosine A1 Receptor Agonists; Adenosine-5'-(N-ethylcarboxamide); Asthma; Bronchi; Bronchoconstriction; Capsaicin; Female; Humans; Lung Neoplasms; Male; Middle Aged; Organ Culture Techniques; Receptor, Adenosine A1; Sensory System Agents; Vasodilator Agents | 2011 |
A3 adenosine receptor-mediated p53-dependent apoptosis in Lu-65 human lung cancer cells.
Topics: Adenosine; Adenosine A3 Receptor Agonists; Adenosine A3 Receptor Antagonists; Apoptosis; Caspases; Cell Line, Tumor; Cell Survival; Dihydropyridines; Enzyme Activation; Gene Expression Regulation; Gene Knockdown Techniques; Humans; Lung Neoplasms; Proto-Oncogene Proteins c-bcl-2; Receptor, Adenosine A3; RNA Interference; Tumor Suppressor Protein p53 | 2012 |
Epigenetic therapy with 3-deazaneplanocin A, an inhibitor of the histone methyltransferase EZH2, inhibits growth of non-small cell lung cancer cells.
Topics: Adenosine; Antineoplastic Agents; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor p27; Enhancer of Zeste Homolog 2 Protein; Epigenesis, Genetic; G1 Phase Cell Cycle Checkpoints; Gene Expression; Gene Knockdown Techniques; Histones; Humans; Inhibitory Concentration 50; Lung Neoplasms; Methylation; Neoplasm Proteins; Polycomb Repressive Complex 2; Protein Processing, Post-Translational; RNA Interference; Transcription Factors | 2012 |
Inhibition of cell proliferation through cell cycle arrest and apoptosis by thio-Cl-IB-MECA, a novel A3 adenosine receptor agonist, in human lung cancer cells.
Topics: Adenosine; Adenosine A3 Receptor Agonists; Antineoplastic Agents; Apoptosis; Blotting, Western; Caspases; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Enzyme Activation; Gene Expression; Humans; Lung Neoplasms; Proto-Oncogene Proteins c-akt | 2008 |
The extracellular fluid of solid carcinomas contains immunosuppressive concentrations of adenosine.
Topics: Adenosine; Animals; Coformycin; Colonic Neoplasms; Enzyme Inhibitors; Extracellular Space; Female; Fibrosarcoma; Humans; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Nude; Microdialysis; Neoplasm Transplantation; Time Factors; Tubercidin; Tumor Cells, Cultured | 1997 |
Mitochondrial ischemia-reoxygenation injury and plasma membrane integrity in human endothelial cells.
Topics: Adenosine; Allopurinol; Cell Membrane; Cell Membrane Permeability; Cells, Cultured; Digitonin; Glucose; Glutathione; Humans; Insulin; Lung Neoplasms; Mannitol; Mitochondria; Organ Preservation Solutions; Oxygen Consumption; Potassium Chloride; Procaine; Raffinose; Reperfusion Injury; Rotenone; Tumor Cells, Cultured; Umbilical Veins | 1997 |
Effective elimination of lung metastases induced by tumor cells treated with hydrostatic pressure and N-acetyl-L-cysteine.
Topics: Acetylcysteine; Adenosine; Animals; CD4 Antigens; CD8 Antigens; Female; Humans; Hydrostatic Pressure; Hypersensitivity, Delayed; Lung; Lung Neoplasms; Lymphocyte Culture Test, Mixed; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Neoplasm Metastasis; Spleen | 2000 |
The A3 adenosine receptor as a new target for cancer therapy and chemoprotection.
Topics: Adenosine; Administration, Oral; Animals; Antineoplastic Agents, Alkylating; Bone Marrow Cells; Cell Cycle; Cell Division; Cyclophosphamide; Granulocyte Colony-Stimulating Factor; Granulocyte-Macrophage Colony-Stimulating Factor; In Situ Hybridization, Fluorescence; Lung Neoplasms; Male; Mice; Mice, Inbred C57BL; Neoplasms; Neoplasms, Experimental; Protein Binding; Receptor, Adenosine A3; Receptors, Purinergic P1; Telomere; Tumor Cells, Cultured | 2001 |
N6(Methylnitroso)adenosine: a carcinogenic nitrosamine derived from a naturally-occurring nucleoside.
Topics: Adenosine; Animals; Carcinogens; Female; Liver Neoplasms; Lung Neoplasms; Lymphoma; Male; Maternal-Fetal Exchange; Mice; Neoplasms, Experimental; Nitrosamines; Pregnancy | 1979 |
Induction of reproductive system tumors in mice by N6-(methylnitroso)-adenosine and a tumorigenic effect of its combined precursors.
Topics: Adenocarcinoma; Adenosine; Animals; Female; Leiomyoma; Lung Neoplasms; Male; Mammary Neoplasms, Experimental; Mice; Neoplasms, Experimental; Nitrites; Nitrosamines; Nitroso Compounds; Ovarian Neoplasms; Uterine Neoplasms | 1979 |
1,N6-ethenoadenosine formation, mutagenicity and murine tumor induction as indicators of the generation of an electrophilic epoxide metabolite of the closely related carcinogens ethyl carbamate (urethane) and vinyl carbamate.
Topics: Adenosine; Animals; Ditiocarb; Epoxy Compounds; Ethers, Cyclic; Female; Liver Neoplasms, Experimental; Lung Neoplasms; Magnetic Resonance Spectroscopy; Mice; Microsomes, Liver; Mutagens; Neoplasms, Experimental; Polychlorinated Biphenyls; RNA; Sister Chromatid Exchange; Urethane | 1990 |
Antagonism of voltage-gated calcium channels in small cell carcinomas of patients with and without Lambert-Eaton myasthenic syndrome by autoantibodies omega-conotoxin and adenosine.
Topics: Adenosine; Autoantibodies; Autoimmune Diseases; Calcium; Calcium Channel Blockers; Carcinoma, Small Cell; Humans; Immunoglobulin G; Ion Channels; Lung Neoplasms; Mollusk Venoms; Muscular Diseases; omega-Conotoxin GVIA; Paraneoplastic Syndromes; Tumor Cells, Cultured | 1988 |
Inhibition of in vitro tumor cell invasion by transmethylation inhibitors.
Topics: Adenosine; Animals; Antineoplastic Agents; Carcinoma, Small Cell; Deoxyadenosines; Fibrosarcoma; Humans; Kinetics; Liver Neoplasms, Experimental; Lung Neoplasms; Melanoma, Experimental; Methylation; Neoplasm Invasiveness; Rats; Rats, Inbred Strains; Thionucleosides; Tumor Cells, Cultured | 1989 |
Inhibition of experimental metastasis with indomethacin: role of macrophages and natural killer cells.
Topics: 2-Chloroadenosine; Adenosine; Animals; Carrageenan; Cytotoxicity, Immunologic; Dinoprostone; Female; G(M1) Ganglioside; Glycosphingolipids; Immune Sera; Indomethacin; Killer Cells, Natural; Lung Neoplasms; Macrophages; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Prostaglandins E; Tumor Cells, Cultured | 1988 |
Macrophage involvement in the antitumor activity of a synthetic acyltripeptide (FK-565) against experimental lung carcinoma metastases.
Topics: 2-Chloroadenosine; Adenosine; Adjuvants, Immunologic; Animals; Antineoplastic Agents; Diaminopimelic Acid; In Vitro Techniques; Lung Neoplasms; Lymphokines; Macrophage Activation; Macrophage-Activating Factors; Male; Mice; Mice, Inbred BALB C; Oligopeptides | 1986 |
Inability of anti-asialo-GM1 and 2-chloroadenosine to abrogate maleic anhydride-divinyl ether-induced resistance against experimental murine lung carcinoma metastases.
Topics: 2-Chloroadenosine; Adenosine; Animals; Antibodies; Antigen-Antibody Reactions; Cytotoxicity, Immunologic; G(M1) Ganglioside; Glycosphingolipids; Immunity, Cellular; Immunologic Surveillance; Killer Cells, Natural; Lung Neoplasms; Macrophages; Mice; Mice, Inbred BALB C; Polymers; Pyran Copolymer | 1986 |
Multiple forms of human adenosine deaminase. II. Isolation and properties of a conversion factor from human lung.
Topics: Adenosine; Aminohydrolases; Animals; Autopsy; Chromatography, DEAE-Cellulose; Chromatography, Gel; Electrophoresis, Disc; Electrophoresis, Polyacrylamide Gel; gamma-Globulins; Humans; Immune Sera; Immunodiffusion; Lung; Lung Neoplasms; Macromolecular Substances; Male; Molecular Weight; Precipitin Tests; Rabbits; Sodium Dodecyl Sulfate; Spectrophotometry, Ultraviolet; Tetrazolium Salts; Time Factors | 1973 |